Pediatric Fast Fluid Randomized Controlled Trial

February 26, 2012 updated by: Melissa J Parker, MD, MSc, McMaster Children's Hospital

Factors Affecting Pediatric Isotonic Fluid Resuscitation Efficiency: Impact of Syringe Size

The purpose of this study is to determine the impact of syringe size on the amount of time it takes a health care provider to administer a known volume (900 mL) of resuscitation fluid to a non-clinical, toddler-sized, model. The investigators hypothesize that syringe size will impact fluid resuscitation time.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Surviving Sepsis Guideline for the resuscitation of pediatric septic shock indicates that up to 60 mL/kg of isotonic saline should be administered within the first 15 minutes of resuscitation. There are practical challenges to achieving these benchmarks. Syringes are often used to perform manual fluid resuscitation as they are generally available and health care providers are typically comfortable using them. Health care providers have been observed to have different preferences regarding the syringe size used to perform manual fluid resuscitation. Larger syringes e.g. 60 mL-size requires more force to depress the syringe plunger, due to a larger crosssectional area, but fewer syringes are needed to administer a given volume. Fewer syringes results in less time spent connecting and disconnecting syringes, which contributes to total fluid resuscitation time using this technique.

Consenting participants will be randomly assigned (by an independent Randomization Coordinator) to one of four syringe size groups (10 mL, 20 mL, 30 mL, 60 mL sizes). The allocation sequence is therefore concealed. After undergoing a standardization procedure, each participant will be instructed to administer 900 mL of 0.9% normal saline using pre-filled provided syringes by manual push as rapidly as possible using the disconnect-reconnect method. Participants will be advised to consider that they are in a situation where they are resuscitating a 15 kg child (represented by the model) in decompensated shock. Syringes for each 300 mL (20 mL/kg) aliquot will be colour-coded for identification purposes.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8N3Z5
        • Hamilton Health Sciences, McMaster Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consenting health care staff and health care students capable of performing manual syringe bolus fluid administration

Exclusion Criteria:

  • Non-English speaking individuals
  • Any condition that would impact upon the individual's ability to perform manual fluid resuscitation e.g. limited hand strength or dexterity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 10 mL syringe size
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation. All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization. Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
  • BD 10 mL syringe with Luer-Lok Tip (Ref 309604)
  • BD 20 mL syringe with Luer-Lok Tip (Ref 309661)
  • BD 30 mL syringe with Luer-Lok Tip (Ref 309650)
  • BD 60 mL syringe with Luer-Lok Tip (Ref 309653)
EXPERIMENTAL: 20 mL syringe size
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation. All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization. Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
  • BD 10 mL syringe with Luer-Lok Tip (Ref 309604)
  • BD 20 mL syringe with Luer-Lok Tip (Ref 309661)
  • BD 30 mL syringe with Luer-Lok Tip (Ref 309650)
  • BD 60 mL syringe with Luer-Lok Tip (Ref 309653)
EXPERIMENTAL: 30 mL syringe size
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation. All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization. Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
  • BD 10 mL syringe with Luer-Lok Tip (Ref 309604)
  • BD 20 mL syringe with Luer-Lok Tip (Ref 309661)
  • BD 30 mL syringe with Luer-Lok Tip (Ref 309650)
  • BD 60 mL syringe with Luer-Lok Tip (Ref 309653)
EXPERIMENTAL: 60 mL syringe size
The intervention consists of the administration of 900 mL of Normal Saline to the model using the "Disconnection- Reconnection" method of manual fluid resuscitation. All syringes (syringe size based on study arm) will be prepared by research staff following subject randomization. Each subject will take the prepared syringes, and sequentially administer them to the model by 1. Selecting and connecting a fluid-filled syringe to the catheter extension set to permit fluid administration 2. Manually administering the fluid to the model by depressing the syringe plunger 3. Disconnecting and discarding the empty syringe 4. Repeating steps 1-3 as fast as possible until all 900 mL has been administered.
Other Names:
  • BD 10 mL syringe with Luer-Lok Tip (Ref 309604)
  • BD 20 mL syringe with Luer-Lok Tip (Ref 309661)
  • BD 30 mL syringe with Luer-Lok Tip (Ref 309650)
  • BD 60 mL syringe with Luer-Lok Tip (Ref 309653)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Intervention Time
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
Subject is randomized and the intervention is performed the same day. Start Intervention Time (time zero): Subject begins administering the intervention; End Intervention Time: Subject has completed the intervention (900 mL of Saline has been administered); Total Intervention Time = End Intervention Time - Start Intervention Time. All testing is being video recorded. A blinded outcome assessor will review the video tapes and based upon clear, a priori defined, definitions will determine the Start Intervention Time and the End Intervention Time for each subject.
From Date of Subject Randomization until Date Intervention Completed (Day 1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to administer each of three sequential 300 mL fluid boluses
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)

Bolus 1 Time = Time at 300 mL administered MINUS Start Intervention Time; Bolus 2 Time = Time at 600 mL administered MINUS Time at 300 mL administered; Bolus 3 Time = Time at 900 mL administered (End Intervention Time) MINUS Time at 600 mL administered.

Syringes are marked with coloured tape to facilitate identification according to Bolus number (Bolus 1 - Green; Bolus 2 - Yellow; Bolus 3 - Red).

From Date of Subject Randomization until Date Intervention Completed (Day 1)
Amount of normal saline actually administered to the model
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
The normal saline administered to the model travels via conduit tubing in a dependent fashion to a graduated cylinder where it is collected for measurement upon completion of testing for each subject.
From Date of Subject Randomization until Date Intervention Completed (Day 1)
The proportion of subjects in each group that dislodge the IV catheter during testing.
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
Any IV catheter dislodgement episodes will be recorded. The catheter used in this model is a 1.00 inch, 22-gauge, Insyte Autoguard IV catheter. The proximal end (hub) of the IV catheter is transfixed to the hand of the mannequin in typical clinical fashion, while the distal end is located within conduit tubing that leads to a 1 litre graduated cylinder. Connected to the hub of the IV catheter is a 7 inch long IV Catheter Extension Set.
From Date of Subject Randomization until Date Intervention Completed (Day 1)
Self-reported comfort of health care providers while performing the study intervention
Time Frame: From Date of Subject Randomization until Date Intervention Completed (Day 1)
Based on responses to questionnaire that subjects are asked to complete following completion of the intervention
From Date of Subject Randomization until Date Intervention Completed (Day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melissa J Parker, MD, MSc, McMaster Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (ACTUAL)

December 1, 2011

Study Completion (ACTUAL)

January 1, 2012

Study Registration Dates

First Submitted

December 5, 2011

First Submitted That Met QC Criteria

December 14, 2011

First Posted (ESTIMATE)

December 16, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

February 28, 2012

Last Update Submitted That Met QC Criteria

February 26, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 11-272

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Resuscitation

Clinical Trials on 900 mL of 0.9% Normal Saline

Subscribe